Table 5.
Serum sTLR4 (pg/ml) | Group I (n = 50) | Group II (n = 50) | Control (n = 50) | H | p | Sig. bet. grps. |
---|---|---|---|---|---|---|
Mean ±SD | 2465.4 ±3501.8 | 4759.7 ±5176.2 | 1242.3 ±53.9 | 48.569* | < 0.001* | p1 = 0.281 |
Median | 1378 | 2416.5 | 1242.3 | 3 | 3 | p2 < 0.001* |
Min–Max | 1164–14250 | 1148.5–18550 | 1095–1347 | 3 | 3 | p3 < 0.001* |
Group I – early, Group II – advanced, H – Kruskal-Wallis test, Pairwise comparison between each 2 groups was done using post hoc test (Dunn’s for multiple comparisons test), p1 – p value for comparing between early and advanced, p2 – p value for comparing between early and control, p3 – p value for comparing between advanced and control, *statistically significant at p ≤ 0.05